glp 1 cancer risk GLP-1s may reduce for adults with obesity Dr. - The GLP-1 cancer

NATIONAL BESTSELLER A board-certified physician shares her must-have guide to using GLP-1 medications, such as Ozempic, Wegovy, Mounjaro, and Zepbound, to reverse obesity and take charge of your...

Imitation drugs, unexpected benefits, serious pitfallsheres what comes next as GLP-1 medications continue to rise in popularity

Written by Braylee Wardwell, PharmD and Marissa Salvo, PharmD, BCACP, FCPA, FCCPWhat is Cirrhosis?Cirrhosis is a condition where healthy liver tissue is replaced by scar tissue

A flexible nourishing meal pack designed for GLP-1 weight loss meds

In real-world settings multiple factors contribute to non-persistence, including adverse effects, high cost-sharing and weight loss not meeting patients' expectations.

The growing prevalence of metabolic disease, CKD, and ASCVD have prompted investigation into the role of GLP-1R agonists in mitigating cardiovascular and metabolic risks, particularly within the framework of Cardiovascular-Kidney-Metabolic (CKM) Syndrome, irrespective of diabetic status